Global Remdesivir Market Overview And Prospects
Learn about the global remdesivir market through The Business Research Company, which provides information on remdesivir market size, remdesivir market drivers and restraints, remdesivir market players, the COVID-19 impact on the remdesivir market, and more.
Our annual holiday sale is here! Get your discounted market research reports today.
The global remdesivir market is expected to grow from $1.98 billion in 2020 to $2.55 billion in 2021 at a compound annual growth rate (CAGR) of 28.8%. The growth is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The market is expected to reach $6.89 billion in 2025 at a CAGR of 28%.
Increasing prevalence of COVID-19 disease globally is expected to drive innovation in remdesivir manufacturing, thus driving the market during the forecast period.
Request A Sample For The Global Remdesivir Market Report:
The remdesivir market consists of sales of remdesivir drugs currently found effective in treating the COVID-19 disease. Remdesivir (RDV) is one of the promising drugs used currently for the treatment of the COVID-19 disease. Gilead, the US drug manufacturer is expanding its Remdesivir production due to the high demand for this drug. RDV is a synthetic compound throughout the class of antiviral drugs that target RNA synthesis.
Global remdesivir market segments include:
By Route Of Administration: Oral, Intravenous
By Dosage Form: Tablets, Frozen Solution, Lyophilized Solution
By Distribution Channel: Hospitals, Clinics, Drug Stores/Pharmacies, Online, Others
By Geography: The market is segmented into North America, South America, Asia-Pacific, Eastern Europe, Western Europe, Middle East and Africa.
TBRC’s remdesivir market report covers:
Major Market Players: Gilead Sciences, Inc., Bright Gene, Hainan Haiyao, Kelun Pharma, Hunan Warrant Pharmaceutical, Cipla, Pfizer, Merck, Cayman Chemical, and Dr. Reddy’s Laboratories.
Regions: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa.
Countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.
Time Series: Five years historic (2015-20) and ten years forecast (2021-2025-2030)
The Remdesivir Global Market Report 2021: COVID-19 Growth and Change to 2030 is one of a series of new reports from The Business Research Company that provides remdesivir market overviews, analyzes and forecasts market size, share, remdesivir market players, remdesivir market segments and geographies, leading competitor revenues, profiles and market shares.
TBRC’s remdesivir market report identifies top countries and segments for opportunities and strategies based on market trends and leading competitors’ approaches.
Here is a list of similar reports from The Business Research Company:
Interested to know more about The Business Research Company?
The Business Research Company has published over 1000 industry reports, covering over 2500 market segments and 60 geographies. The reports draw on 150,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. The reports are updated with a detailed analysis of the impact of COVID-19 on various markets.
Read more about us at https://www.thebusinessresearchcompany.com/about-the-business-research-company.aspx
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Follow us on LinkedIn: https://in.linkedin.com/company/the-business-research-company
Follow us on Twitter: https://twitter.com/tbrc_info
Check out our Blog: https://blog.tbrc.info/
Check out our Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model